257 related articles for article (PubMed ID: 21441785)
1. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.
Beck A; Wurch T; Reichert JM
MAbs; 2011; 3(2):111-32. PubMed ID: 21441785
[TBL] [Abstract][Full Text] [Related]
2. 4th European Antibody Congress 2008: December 1-3, 2008, Geneva, Switzerland.
Beck A; Hanala S; Reichert JM
MAbs; 2009; 1(2):93-103. PubMed ID: 20061813
[TBL] [Abstract][Full Text] [Related]
3. Keystone Symposium on Antibodies as Drugs: March 27-April 1, 2009, Whistler, BC CA.
Wurch T; Larbouret C; Robert B
MAbs; 2009; 1(4):318-25. PubMed ID: 20068403
[TBL] [Abstract][Full Text] [Related]
4. 8(th) Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland.
Beck A; Carter PJ; Gerber HP; Lugovskoy AA; Wurch T; Junutula JR; Kontermann RE; Mabry R
MAbs; 2013; 5(3):339-57. PubMed ID: 23493119
[TBL] [Abstract][Full Text] [Related]
5. 7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.
Lugovskoy AA; Reichert JM; Beck A
MAbs; 2012; 4(2):134-52. PubMed ID: 22453093
[TBL] [Abstract][Full Text] [Related]
6. 9th annual European Antibody Congress, November 11-13, 2013, Geneva, Switzerland.
Reichert JM; Beck A; Lugovskoy AA; Wurch T; Coats S; Brezski RJ
MAbs; 2014; 6(2):309-26. PubMed ID: 24492298
[TBL] [Abstract][Full Text] [Related]
7. Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, Germany.
Beck A; Lambert J; Sun M; Lin K
MAbs; 2012; 4(6):637-47. PubMed ID: 22909934
[TBL] [Abstract][Full Text] [Related]
8. World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA.
Klinguer-Hamour C; Strop P; Shah DK; Ducry L; Xu A; Beck A
MAbs; 2014; 6(1):18-29. PubMed ID: 24423618
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
10. World Antibody Drug Conjugate Summit Europe: February 21-23, 2011; Frankfurt, Germany.
Beck A; Senter P; Chari R
MAbs; 2011; 3(4):331-7. PubMed ID: 21691144
[TBL] [Abstract][Full Text] [Related]
11. 5th European Antibody Congress 2009: November 30–December 2, 2009, Geneva, Switzerland.
Beck A; Reichert JM; Wurch T
MAbs; 2010; 2(2):108-28. PubMed ID: 20179425
[No Abstract] [Full Text] [Related]
12. CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.
Newsome SD; Aliotta PJ; Bainbridge J; Bennett SE; Cutter G; Fenton K; Lublin F; Northrop D; Rintell D; Walker BD; Weigel M; Zackowski K; Jones DE
Int J MS Care; 2016; 18(6):314-323. PubMed ID: 27999526
[TBL] [Abstract][Full Text] [Related]
13. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.
Hidalgo-Mazzei D; Berk M; Cipriani A; Cleare AJ; Florio AD; Dietch D; Geddes JR; Goodwin GM; Grunze H; Hayes JF; Jones I; Kasper S; Macritchie K; McAllister-Williams RH; Morriss R; Nayrouz S; Pappa S; Soares JC; Smith DJ; Suppes T; Talbot P; Vieta E; Watson S; Yatham LN; Young AH; Stokes PRA
Br J Psychiatry; 2019 Jan; 214(1):27-35. PubMed ID: 30520709
[TBL] [Abstract][Full Text] [Related]
14. World Bispecific Antibody Summit, September 27-28, 2011, Boston, MA.
Dhimolea E; Reichert JM
MAbs; 2012; 4(1):4-13. PubMed ID: 22327426
[TBL] [Abstract][Full Text] [Related]
15. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
[TBL] [Abstract][Full Text] [Related]
16. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
Arnett SO; Teillaud JL; Wurch T; Reichert JM; Dunlop C; Huber M
MAbs; 2011; 3(2):133-52. PubMed ID: 21304271
[TBL] [Abstract][Full Text] [Related]
17. Ketamine: stimulating antidepressant treatment?
Malhi GS; Byrow Y; Cassidy F; Cipriani A; Demyttenaere K; Frye MA; Gitlin M; Kennedy SH; Ketter TA; Lam RW; McShane R; Mitchell AJ; Ostacher MJ; Rizvi SJ; Thase ME; Tohen M
BJPsych Open; 2016 May; 2(3):e5-e9. PubMed ID: 27703782
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.
Fabbri C; Kasper S; Kautzky A; Bartova L; Dold M; Zohar J; Souery D; Montgomery S; Albani D; Raimondi I; Dikeos D; Rujescu D; Uher R; Lewis CM; Mendlewicz J; Serretti A
Br J Psychiatry; 2019 Jan; 214(1):36-41. PubMed ID: 30468137
[TBL] [Abstract][Full Text] [Related]
19. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.
Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM
MAbs; 2012; 4(6):648-52. PubMed ID: 23007482
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects.
Smith MR; Sandhu S; George DJ; Chi KN; Saad F; Thiery-Vuillemin A; Stàhl O; Olmos D; Danila DC; Gafanov R; Castro E; Moon H; Joshua AM; Mason GE; Espina BM; Liu Y; Lopez-Gitlitz A; Francis P; Bevans KB; Fizazi K
J Manag Care Spec Pharm; 2023 Jul; 29(7):758-768. PubMed ID: 37404070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
